AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 91 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $975 | +3.3% | 20,848 | +24.1% | 0.00% | 0.0% |
| Q2 2023 | $944 | +51.3% | 16,800 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $624 | +32.8% | 16,800 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $470 | -99.9% | 16,800 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $477,000 | -17.6% | 16,800 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $579,000 | -5.4% | 16,800 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $612,000 | +74.4% | 16,800 | +9.8% | 0.00% | 0.0% |
| Q4 2021 | $351,000 | +24.0% | 15,300 | +2.7% | 0.00% | 0.0% |
| Q3 2021 | $283,000 | -5.4% | 14,900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $299,000 | +12.4% | 14,900 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $266,000 | -11.0% | 14,900 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $299,000 | +9.1% | 14,900 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $274,000 | -11.9% | 14,900 | -3.2% | 0.00% | -50.0% |
| Q3 2019 | $311,000 | -75.5% | 15,400 | -74.7% | 0.00% | -66.7% |
| Q2 2019 | $1,268,000 | +268.6% | 60,800 | +225.1% | 0.01% | +200.0% |
| Q1 2019 | $344,000 | +12.1% | 18,700 | +21.4% | 0.00% | 0.0% |
| Q4 2018 | $307,000 | -10.8% | 15,400 | -17.6% | 0.00% | 0.0% |
| Q3 2018 | $344,000 | +15.4% | 18,700 | -2.6% | 0.00% | 0.0% |
| Q2 2018 | $298,000 | -16.1% | 19,200 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $355,000 | -3.0% | 19,200 | -22.0% | 0.00% | -33.3% |
| Q4 2017 | $366,000 | 0.0% | 24,600 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $366,000 | -15.5% | 24,600 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $433,000 | +19.6% | 24,600 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $362,000 | -26.6% | 24,600 | -7.5% | 0.00% | -40.0% |
| Q4 2016 | $493,000 | +6.5% | 26,600 | +8.1% | 0.01% | 0.0% |
| Q3 2016 | $463,000 | +16.9% | 24,600 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $396,000 | +69.2% | 24,600 | +25.5% | 0.01% | +66.7% |
| Q1 2016 | $234,000 | -29.3% | 19,600 | -15.2% | 0.00% | -25.0% |
| Q4 2015 | $331,000 | +25.9% | 23,100 | +2.7% | 0.00% | +33.3% |
| Q3 2015 | $263,000 | -31.0% | 22,500 | +3.7% | 0.00% | -40.0% |
| Q2 2015 | $381,000 | +21.7% | 21,700 | +3.8% | 0.01% | +25.0% |
| Q1 2015 | $313,000 | – | 20,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
| FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
| First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
| Summit Global Investments | 47,546 | $871,000 | 0.06% |
| WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
| EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |